Specialty Crop Nutrition
Search documents
ICL(ICL) - 2025 Q3 - Earnings Call Presentation
2025-11-12 09:00
Financial Performance - Total sales reached $1.9 billion, a 6% year-over-year increase, with specialties-driven sales up by 3%[5] - Adjusted EBITDA increased by 4% year-over-year to $398 million[5] - Specialties-driven sales amounted to $1.5 billion, with an EBITDA of $251 million[5] Segment Performance - **Industrial Products:** Sales were $295 million, and EBITDA was $67 million, with a 23% EBITDA margin[8] - **Potash:** Sales increased to $453 million, and EBITDA reached $169 million, with a 37% EBITDA margin; average potash CIF price was $353 per ton[13, 16] - **Phosphate Solutions:** Sales were $605 million, and EBITDA was $134 million, with a 22% EBITDA margin; Phosphate Specialties sales were $348 million with $51 million EBITDA, while Phosphate Commodities sales were $257 million with $83 million EBITDA[19, 21] - **Growing Solutions:** Sales were $561 million, and EBITDA was $50 million, with a 9% EBITDA margin[23] Financial Position - Available cash resources totaled $1.5 billion[40] - Net debt to adjusted EBITDA ratio was 1.4x[40] - Quarterly dividend was $62 million, resulting in an annual yield of 2.8%[40] Guidance - The company maintains its full-year 2025 guidance for specialties-driven EBITDA between $0.95 billion and $1.15 billion[45] - Potash sales volumes are expected to be between 4.3 million metric tons and 4.5 million metric tons[45]